Millions of travelers ignored public health warnings and packed into airports over the holidays to see their loved ones. As a result, U.S. hospitals are bracing for the deadliest COVID surge yet this month. Meanwhile, Sherlock Biosciences, which has already made history once with CRISPR, seeks to do so again with an inexpensive, accurate home test that could be a global game-changer.
Podden och tillhörande omslagsbild på den här sidan tillhör Biotechnology Innovation Organization. Innehållet i podden är skapat av Biotechnology Innovation Organization och inte av, eller tillsammans med, Poddtoppen.
